Cancer. 2008 May 15;112(10):2130-42.

The molecular journey from ductal carcinoma in situ to invasive breast cancer.

Source

Breast Center, Baylor College of Medicine, Houston, Texas, USA.

Abstract

Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. DCIS can recur or progress to invasive breast cancer, but the ability to predict the outcome of patients with DCIS remains limited, leading to inappropriate treatment choices. To the authors' knowledge to date, the hunt for molecular prognostic markers for DCIS has been unsuccessful. Emerging technologies, however, are shedding new light on the biologic course of DCIS. In the current study, the authors review recent findings elucidating the molecular journey from DCIS to invasive cancer and discuss how these findings will lead to more effective treatment with minimization of morbidity.

PMID:: 18383519; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. [Breast Cancer Res. 2008]
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM. Breast Cancer Res. 2008; 10(5):R87. Epub 2008 Oct 17.
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. [Mol Oncol. 2010]
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, et al. Mol Oncol. 2010 Aug; 4(4):357-68. Epub 2010 Jun 26.
Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast. [Jpn J Clin Oncol. 2003]
Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast.
Amari M, Moriya T, Ishida T, Harada Y, Ohnuki K, Takeda M, Sasano H, Horii A, Ohuchi N. Jpn J Clin Oncol. 2003 Nov; 33(11):556-62.
Review Biology of ductal carcinoma in situ classification based on biologic potential. [Am J Clin Oncol. 2006]
Review Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL, Chung MA. Am J Clin Oncol. 2006 Jun; 29(3):305-10.
Review The natural history of ductal carcinoma in situ of the breast: a review. [Breast Cancer Res Treat. 2006]
Review The natural history of ductal carcinoma in situ of the breast: a review.
Erbas B, Provenzano E, Armes J, Gertig D. Breast Cancer Res Treat. 2006 May; 97(2):135-44. Epub 2005 Dec 1.

See reviews... See all...

Cited by 15 PubMed Central articles

A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy. [Int J Breast Cancer. 2011]
A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy.
Sarode VR, Han JS, Morris DH, Peng Y, Rao R. Int J Breast Cancer. 2011; 2011:217060. Epub 2011 Aug 17.
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. [Cell Oncol (Dordr). 2011]
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
Moelans CB, de Wegers RA, Monsuurs HN, Maess AH, van Diest PJ. Cell Oncol (Dordr). 2011 Oct; 34(5):475-82. Epub 2011 May 6.
Identification of early molecular markers for breast cancer. [Mol Cancer. 2011]
Identification of early molecular markers for breast cancer.
Kretschmer C, Sterner-Kock A, Siedentopf F, Schoenegg W, Schlag PM, Kemmner W. Mol Cancer. 2011 Feb 11; 10(1):15. Epub 2011 Feb 11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The molecular journey from ductal carcinoma in situ to invasive breast cancer.
The molecular journey from ductal carcinoma in situ to invasive breast cancer.
Cancer. 2008 May 15 ;112(10):2130-42.

PubMed
Predicting progression in primary progressive multiple sclerosis: a 10-year mult...
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study.
Ann Neurol. 2008 Jun ;63(6):790-3.

PubMed
Identification of multiple CpG islands and associated conserved sequences in a c...
Identification of multiple CpG islands and associated conserved sequences in a candidate region for the Huntington disease gene.
Genomics. 1991 Dec ;11(4):1113-24.

PubMed
A mixture model of nuchal translucency thickness in screening for chromosomal de...
A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Ultrasound Obstet Gynecol. 2008 Apr ;31(4):376-83.

PubMed
High prevalence of temporomandibular joint arthritis at disease onset in childre...
High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound.
Arthritis Rheum. 2008 Apr ;58(4):1189-96.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: